Indeed, our ongoing studies have demonstrated promising evidence of efficacy for FAP‐targeting CAR‐T cells in a mouse xenograft model of glioblastoma, even where intratumoral expression of FAP is heterogeneous, and a distinct lack of toxicity (manuscript in preparation). Here, FAP is linked to glioblastoma.